Triggering receptor expressed on myeloid cells (TREM) like transcript-1 (TLT-1) is a membrane protein receptor found in a-granules of platelets and megakaryocytes. Upon platelet activation TLT-1 is rapidly brought to the surface of platelets. Recently, we demonstrated that activated platelets release a soluble form of TLT-1 (sTLT-1) that is found in serum but not in the plasma of healthy individuals and can enhance platelet aggregation in vitro. Furthermore, evaluation of patients diagnosed with inflammatory diseases, such as sepsis, show that these patients have significantly elevated levels of sTLT-1 in their blood. Accordingly, mice deficient in TLT-1 are predisposed to bleeding in response to an inflammatory challenge; however, the mechanism of TLT-1 function remains unknown. In this investigation, we demonstrate an increase in the amount of platelets that adhere to endothelial cell monolayers in the presence of recombinant sTLT-1 (rsTLT-1). Additionally, we present evidence that rsTLT-1 increases platelet adherence to glass slides by stimulating actin polymerization in platelets, as determined by increased staining of rodamine phalloidin. These results suggest that during inflammation, sTLT-1 may mediate hemostasis by enhancing actin polymerization, resulting in increased platelet aggregation and adherence to the endothelium.
Introduction
Inflammation during the progress of sepsis and viral infections such as dengue fever often invoke the activation of our hemostatic system [1] [2] [3] . The clinical manifestations are associated with a hypovolemic shock that promotes hemoconcentration and low blood pressure, resulting from an acute increase in capillary permeability, and possibly death [2, 4, 5] . Release of cytokines, such as tissue necrosis factor (TNF-a) and interleukin 1b (IL-1b) enhances neutrophil evagination into the tissues, subsequently leading to vascular leakage [6] . Both platelets and endothelial cells are called upon to control the loss of blood and plasma from the vessels through receptor engagement, release of granule contents, and remodeling of their actin cytoskeletons [7] [8] [9] . Storage granules in endothelial cells (weibel palade bodies), and in platelets (alpha and dense granules) play a major role in maintaining vascular integrity. Upon activation, platelets and endothelial cells release proteins from the storage granules into the plasma that enhance their ability to stop blood leakage. The release reaction from platelet granules is accompanied by an increase in the presence of several receptor proteins on the surface of the cells [10] . It has been shown that receptors such P-selectin [11, 12] and TREM like transcript-1 (TLT-1) can be found in high concentrations on the surface of the platelet membrane upon platelet activation [13] as the granules of the resting platelet merge with the cell membrane, releasing their soluble contents and displaying membrane-bound receptors previously undisplayed at the cell surface. Although much work has gone into the understanding the role of P-selectin in inflammation and hemostasis, the role of TLT-1 in platelet function remains somewhat an enigma [14, 15] .
Studies in TLT-1 null mice (TLT À/À
) have demonstrated an inability of their platelets to aggregate efficiently [16] . Additionally, TLT À/À mice were shown to have extended tail-bleeding times. Lipopolysaccharide (LPS)-treated TLT-1 À/À mice showed higher plasma levels of D dimers compared with wild-type mice and they were more susceptible to death from the endotoxin challenge [16] . Accordingly, TLT-1 -/-mice were predisposed to hemorrhage associated with the Shwartzman reaction, a specific localized inflammatory lesion. Collectively, these results suggest that TLT-1 plays an important role in maintaining hemostasis during inflammation.
Recently, our laboratory demonstrated that activated platelets release a soluble form of TLT-1 (sTLT-1) that is found in serum but not in the plasma of healthy individuals. However, upon investigation of plasma from patients diagnosed with sepsis [16] or acute viral infections (unpublished observations), we demonstrated that these patients had significantly increased levels of sTLT-1 in their plasma in contrast to healthy individuals. In septic individuals, the presence of sTLT-1 correlated the presence of disseminated intravascular coagulation [16] . Previous studies have shown that thrombin-induced platelet aggregation can be specifically inhibited using human single-chain Fv antibodies against TLT-1 [17] . Our studies further demonstrated that a recombinant, soluble (rs)TLT-1 increases platelet aggregation when using washed platelets and various agonists [16] . The ability of sTLT-1 to increase platelet reactivity to agonists suggests that TLT-1 may modulate hemostatic function in part by release of a soluble fragment. To gain insight into the mechanism of sTLT-1's affect on hemostasis, we examined the effect of rsTLT-1 on platelet adhesion to endothelial cells and evaluated the effects of rsTLT-1 on actin polymerization to identify clues to the mechanisms of TLT-1 function.
Materials and methods

Platelet isolation
The Universidad Central del Caribe, Escuela del Medicina (Institutional Review Board (Federalwide Assurance no. FWA00001103) approved the study, and volunteers provided written informed consent before enrollment (protocol no. 200619; primary investigator, A. Valance Washington). Platelets were isolated as described previously [16] . Briefly, blood was obtained by venipuncture from healthy volunteers who had not have taken any anti-inflammatory drugs for the previous 7 days. Blood was drawn into polypropylene syringes containing one-sixth volume of 3.8% trisodium citrate and centrifuged at 800 g for 20 min to obtain platelet-rich plasma (PRP). Platelets were sedimented by centrifugation at 2200 g for 10 min and washed twice with 10 ml of Hepes Tyrode's buffer (10 mmol/l Hepes, 0.5 mmol/l MgCl 2 , 130 mmol/l NaCl, 4 mmol/l KCl, 1 mmol/l CaCl 2 , and 5 mmol/l glucose, pH 7.4). Platelets stained with calcein were incubated with 1 mmol/l calcein-acetoxymethyl ester (Molecular Probes Inc., Eugene, Oregon, USA) in the dark for 30 min at 378C. All centrifugations were done at room temperature in the presence of 1 mmol/l prostaglandin E1 and 0.02 U/ml of asparase. To remove excess of calcein, labeled platelets were washed once with Hepes-Tyrode's buffer containing 0.3% BSA. Then the density of platelets was adjusted to 1.3 Â 10 8 per ml in Hepes-tyrode's buffer containing 10% newborn calf serum. Platelets were activated with 0.5 U/ml human thrombin for 10 min. Hirudin (1U/ml) was added to stop the reaction.
Bovine aortic endothelial cells Bovine aortic endothelial cells (BAEC) were prepared as described previously [18] , briefly the cells were maintained under a humidified atmosphere of 95% air and 5% CO 2 at 378C. The cells were seeded on 12 well plates 4 days before each assay. Cells were cultured in RPMI 1640 medium (20% bovine calf serum, 90 ug/ml Heparin, 50 ug/ml endothelial growth factor) and allowed the cells to grow to confluence in 12 well plates.
Adherence assay BAEC were activated with 150 nmol/l of Thromboxane A 2 (TxA 2 ) for 15 min at 378C in RPMI media. After 15 min BAEC were washed twice with RPMI media and incubated with 600 ml of Hepes-Tyrode's buffer with 2 mmol/l CaCl 2 and 40 ml of the solution of calcein-treated human platelets. The platelets were either resting or thrombin activated and incubation was carried out either in the presence or absence of rsTLT-1 for 30 min at 378C. Unbound platelets were removed by two washes with PBS. BAEC were harvested mechanically, washed once and then fixed with 80% ethanol on ice for 30 min. The cells were resuspended in 500 ml of PBS containing 0.1% Triton X-100, 5 mg/ml propidium iodine and 50 mg/ml ribonuclease A. We analyzed adherence by flow cytometery. Bound platelets were identified by the increase in events in the endothelial cell platelet (PEC) gate (shown in Fig. 2c ). Results are expressed as the average number of events in the PEC gate from at least three experiments. At least 20 000 events were counted per sample.
Confocal microscopy
Platelets were seeded on glass slides with fibrinogen matrixes (100 mg/ml) in the presence of different concentrations of rsTLT-1 (0, 25, 50, and 100 mg/ml). Platelets were allowed to adhere for 5 min then the slides were washed with tyrodes and fixed with Cytofix/Cytoperm (BD Science) for 20 min at 48C. Platelets were stained with rhodamine phalloidin to determine the changes in actin polymerization (red) and counter stained with anti-CD41 (the integrin aIIb also known as platelet GPIIb: US Biologicals: Swampscott, Massachusetts, USA cat#C2394-10 clone 7H138). Because phalloidin only binds to polymerized actin we correlated platelet spreading with increased rodamine intensity. Ten fields of each slide were counted in each of three experiments. The quantification of platelet binding and spreading was completed by using the Metamorph program (Molecular Devices, Downingtown, Pennsylvania, USA).
Statistical analysis
Analysis was completed with Prism software (version 5.01; Graph-Pad Software, San Diego, California, USA). Platelet binding to endothelial cells, platelet spreading, and platelet binding to the fibrinogen matrixes were expressed as means AE SD. We used a two-tailed Student's t test and a P < 0.05 was considered statistically significant.
Results
Soluble TLT-1 enhances platelet-endothelial cells binding interactions
We have recently demonstrated that the addition of rsTLT-1 to platelet aggregation assays significantly increases the ability of platelets to aggregate [16] . We hypothesized that the rsTLT-1 mediated enhanced aggregation would translate to increased platelet adhesion to endothelial cells. To address this possibility, we modified the protocol of Kakutani et al. [18] , which used bovine aortic endothelial cells (BAEC) to measure platelet adhesion to endothelium in a static assay. Recent reports demonstrate that TxA 2 plays a formidable role in mediating neutrophil and platelet adhesion to endothelial cells [19] . Because we have consistently seen the greatest TLT-1 mediated platelet inhibition when we used TxA 2 to activate platelets and recent reports demonstrate that TxA 2 plays a formidable role in mediating leukocyte and platelet adhesion to and vascular leakage from the endothelium, we used TxA 2 to activate the endothelial cells. TxA 2 causes cellular withdrawal and shrinkage and as expected TxA 2 activation of endothelial cells caused greater endothelial cell loss during harvesting. The greater cell loss is reflected in the flow cytometry shown in Fig. 1(a and b) where we consistently counted less endothelial cells from wells where activated endothelial cells were harvested.
Platelets were treated with the fluorescent intercellular cell dye calcein before addition to endothelial cells. Resting and activated calcein-treated platelets demonstrated a typical platelet scatter with a classical subtle shift in fluorescence once activated as shown in Fig. 1c  and d . Resting or activated platelets were incubated with either activated or resting endothelial cells for 30 min at 37 o C. Adherent platelets were monitored by flow cytometry, as described in materials and methods. Endothelial cell activation caused a 30% increase in the total numbers of resting platelets that adhered compared with resting platelets that adhered to resting endothelial cells (Fig. 1g) . The addition of previously activated platelets to resting or activated endothelial cells show a 25 and 43% reduction respectively in average total numbers of adherent platelets.
Once, we established the parameters of our experimental system, we repeated these experiments in either the presence or absence of rsTLT-1. Figure 2a and b give an example of the changes seen within the PEC gate with the addition of rsTLT-1 (Fig. 2b) to activated BAEC and resting platelets. Examination of platelet-endothelial cell aggregates demonstrated that rsTLT-1 has an augmentative effect on platelet adherence to BAEC in all the conditions tested when compared with controls ( Fig. 2c   and d) . Using resting platelets and resting endothelial cells, addition of rsTLT-1 increased the average observed binding events from 320 AE 46 to 460 AE 51. Using activated platelets with resting endothelial cells the observed binding events increased from 297 AE 109 to 456 AE 248. The effect of added rsTLT-1 was much more pronounced on platelet binding to activated BAEC. Using resting platelets, the addition of rsTLT-
TLT-1 enhances actin polymerization and platelet binding to fibrinogen matrixes
Previous work with TLT-1 using scFvs [17] to inhibit platelet aggregation showed that the scFv-mediated inhibition fails to stop P-selectin expression suggesting that the TLT-1 mediated inhibition is downstream of the calcium signal required for a-granule/membrane fusion. These results open the possibility that actin polymerization, which plays an important role downstream of the calcium signal in both platelet activation and adhesion could provide key mechanistic insights to TLT-1 function. To evaluate the potential of actin polymerization playing a role in TLT-1 mediated platelet function, we seeded platelets at 1 Â 10 8 cells on glass slides coated with bovine serum albumin (BSA), fibrinogen, TLT-1, and/or a fibrinogen/TLT-1 mixture and slides were washed after 5 min of incubation at 37 o C. Slides were subsequently stained with rodamine phalloidin, which binds only polymerized actin. Slides were examined by confocal microscopy and evaluated for platelet spreading and adhesion. Confocal microscopy revealed that actin polymerization in platelets increased with increasing TLT-1 concentration (25, 50, or 100 mg/ml) when compared with those allowed to adhere to fibrinogen alone (Fig. 3) . There was no difference in actin polymerization between the slides that contained fibrinogen-only (100 mg/ml), fibrinogen (100 mg/ml)/BSA (50 mg/ml) or BSA-only (100 mg/ml) (data not shown). Recombinant sTLT-1 concentrations of 25, 50, 100 mg/ml yielded a significant difference in the increase of spreading compared with fibrinogen only controls. There was an increase in average platelet radius (Fig. 3f) and area (Fig. 3e) . Average platelet areas observed in photomicrographs increased on average from 33 mm 2 AE 0.3 with fibrinogen-only to 53.38 mm 2 AE 5.2, 45.7 AE 3.1, or 57.8 mm 2 AE 12.1 with addition of 25, 50, or 100 mg/ml of rsTLT-1 respectively (Fig. 3e) . Platelets allowed to adhere for 15 min did not show the dose-dependent difference in actin polymerization (data not shown) suggesting that TLT-1 plays a role early during the process of platelet aggregation and adhesion.
We subsequently measured the amount of platelets that adhered to the fibrinogen and fibrinogen/TLT-1 matrixes (Fig. 4a-d ). Platelets were seeded at 1 Â 10 8 plaplatelets/ml and allowed to adhere for 5 min. Platelets were then stained with rodamine phalloidin and subjected to counting using Metamorph. Consistent with the results from the platelet spreading, we saw an increase in the amount of platelets that adhered in the presence of rsTLT-1 compared with fibrinogen alone. Accordingly, the increase was greatest at the rsTLT-1 concentration 50 mg/ml showing an average increase of 217 AE 12 adherent platelets per 10 fields counted (P ¼ 0.02) (Fig. 4e) . The results are consistent with the results from the endothelial cell experiments.
Discussion
The TLT-1 receptor, to date, has only been identified on platelets. The lineage restriction of TLT-1 suggests that TLT-1 plays a specific role in platelet biology. Current work on the TLT-1 receptor shows that antibodies specific to TLT-1 can inhibit platelet aggregation implying that TLT-1 enhances platelet aggregation. Accordingly, the addition of rsTLT-1 significantly enhances platelet aggregation further supporting an important role for TLT-1 during platelet activation and maintenance of vascular integrity. Consistent with this data, studies with platelets from TLT-1 null mice show that these mice are susceptible to bleeding when challenged with lipopolysaccaride. In our recent publication, we demonstrated that rsTLT-1 binds to fibrinogen suggesting that interaction with fibrinogen may play a key role to understanding how TLT-1 regulates platelet function. Furthermore, our laboratory has found prominent concentrations of sTLT-1 in patient populations suffering from either sepsis or viral syndrome compared with healthy individuals suggesting a potential role for sTLT-1 in maintenance of vascular hemostasis during inflammatory diseases [16] (Washington AV, in preparation). Here, we provide additional evidence for a role for sTLT-1 in platelet-endothelial cell binding interactions and gain insights to the mechanisms of TLT-1 regulation of platelet function.
We performed a platelet-endothelial adherence assay and demonstrated for the first time that TLT-1 plays a role in platelet adherence to endothelial cells in a static assay. Our results show that the addition of rsTLT-1 to either resting or TxA 2 -activated BAEC increased platelet adherence to the BAEC over controls. Using activated platelets appeared to cause a reduction of platelet adherence compared with incubations with resting platelets. Activated endothelial cells have been shown to shrink and lose cell-to-cell contact and detach. The addition of activated platelets may further increase the shrinkage and detachment of the endothelial cells, resulting in a greater variation in the numbers of platelets that adhere under those conditions. Although we consistently found lower numbers of adherent platelets when activated platelets were incubated with activated endothelial cells, the addition of rsTLT-1 increased the total amount of adherent platelets to similar levels seen when resting platelets were used. We have explored the possibility of sTLT-1 increasing adherence to endothelial cells, by investigating the ability of sTLT-1 to directly interact with the extracellular matrix proteins (ECM) vitronectin, collagen, and fibronectin by enzyme by enzyme-linked immunosorbent assay (ELISA). Using the ELISA assay we were, however, unable detect any interactions of sTLT-1 with any of these proteins (data not shown). Therefore, we do not believe that the increased adhesion induced by sTLT-1 is mediated through any of these ECM proteins. Our study opens the possibility of a preserving effect of sTLT-1 on endothelial cells and is currently under investigation in our laboratory. This work also suggests that sTLT-1 may play a role in the maintenance of vascular integrity and that addition of rsTLT-1 to sites of vascular injury may accelerate the cession of bleeding.
TLT Another interesting point is that the most significant difference was seen when rsTLT-1 was incubated with resting platelets. Although resting platelets bound activated endothelial cells more effectively than activated platelets, our results indicate that addition of rsTLT-1 resulted in a statistically significant effect on the interaction between resting platelets and endothelial cells that was not seen with activated platelets under the same conditions. On the basis of these results and recent demonstrations of the importance of a-granule components to platelet function [20] we hypothesize that rsTLT-1 amplifies activation signals from the endothelial cells and/or processing derived signals that may occur during the treatment. A possible mechanism for the Actin polymerization and platelet spreading on sTLT-1 and/or fibrinogen matrixes. (a-d) Representative photomicrographs demonstrating changes in platelet spreading on fibrinogen matrixes (100 mg/ml) in the absence of rsTLT-1 (a) or with 25 mg/ml rsTLT-1 (b), 50 mg/ml rsTLT-1 (c), or 100 mg/ml rsTLT-1 (d). (e) Quantification of platelet spreading and (f) average platelet radius -TLT-1 as evaluated and determined using quantification of rhodamine phalloidin. Platelets are counter stained with anti gpIIb IIIa (green). These are representative of at least three independent experiments. ( Ã ) stars represent a P 0.05. Quantification of the binding of human platelets to fibrinogen rsTLT-1 matrixes. (a-d) Representative photomicrographs demonstrating changes in platelet binding on fibrinogen matrixes (100 mg/ml) in the absence of rsTLT-1 (a) or with 25 mg/ml rsTLT-1 (b), 50 mg/ml rsTLT-1 (c), or 100 mg/ml rsTLT-1 (d). (e) Quantification of platelet: rsTLT-1: fibrinogen matrices as evaluated by quantification of rhodamine phalloidin. Platelets are counter stained with anti gpIIb IIIa (green). These are representative of at least three independent experiments.
increased adherence with resting platelets may lie in the generation of platelet microparticles. It is generally accepted that even with gentle manipulation of platelet samples, platelets will generate microparticles, which have been shown to lower the natural anticoagulant properties of endothelial cells [21] as well as contain the procoagulant tissue factor [22] . The combination of lower endothelial resistance to platelet adherence and low levels of tissue factor in the presence of sTLT-1 may lead to increased platelet degranulation [23, 24] . We hope to be able to discern some of these possibilities in the future. Our results are consistent with the finding that rsTLT-1 enhances platelet aggregation and may indicate that TLT-1 may enhance both platelet-platelet and platelet-endothelial interactions by a single mechanism.
Because actin polymerization plays a large role in platelet aggregation, adhesion, and functions downstream of the calcium signal needed for fusion of a-granules to the platelet membrane, we investigated the ability of TLT-1 to effect actin polymerization. Recombinant sTLT-1 increased platelet spreading and the amount of platelets that adhered to fibrinogen matrixes on glass slides. On the fibrinogen-only slides you can witness the beginnings of filopodia extension as evidence of increased actin polymerization at 5 min (Fig. 3a-d) . However, on the slides with rsTLT-1 there were visually detectable increases in the amount of platelet structures such as filopodia and lamellipodia. These differences were most noticeable on the slides that contained 50 and 100 mg/ml. These results are consistent with the rsTLT-1-mediated adhesion of platelets to the endothelial cells. We attribute the enhanced binding and size of platelets to an increase in the amount of actin structures that were made in the presence of the rsTLT-1 compared with fibrinogen alone. Actin polymerization in platelets is a crucial step in this cascade of events; allowing for a rapid shape change in platelets that leads to the formation of filopodia and lamellipodia on activated platelets. Confocal microscopy revealed that rsTLT-1 promotes platelet cytoskeletal actin polymerization and allows for the formation of filopodia and lamellipodia at the mobile edges of the platelets. Collectively, our studies suggest that TLT-1 may play a visible role in the maintenance of vascular integrity and suggests that the addition of rsTLT-1 to sites of vascular injury may accelerate the cession of bleeding.
Conclusion
Platelets have many receptors, such as gpIIb IIIa, which binds fibrinogen [25] and P-selectin, which is an adhesive molecule that promotes rolling and tethering of platelets and the recruitment of leukocytes to the site of vascular [26] . In addition to all the known platelet receptors, TLT-1 arises as a new receptor, which is capable of augmenting platelet aggregation and platelet-endothelial cell interactions. We conclude that rsTLT-1 functions to augment actin polymerization in platelets leading to increased aggregation and adhesion. Our data suggests that rsTLT-1 mediated actin polymerization may mediate enhanced platelet adhesion to the endothelium in vivo. Although more studies are needed to dissect TLT-1 function and its effects in relation with vascular integrity and its association with platelets behavior, these studies give new insights to platelet-endothelial cell interactions. Since rsTLT-1 modulates actin formation, it could affect not only platelets, but also other cells as well.
